A comprehensive evaluation of a novel targeted-sequencing workflow for Mycobacterium species identification and anti-tuberculosis drug-resistance detection
Frontiers in Cellular and Infection Microbiology · 09.06.2025 · 15
DOI: 10.3389/fcimb.2025.1584237 ↗Kurz gefasst
Evaluationsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 09.06.2025. Verfasst von Xichao Ou und 16 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for Tuberculosis Control and Prevention, Chi…. Hauptthemen laut MEDLINE: Antitubercular Agents, Mycobacterium tuberculosis, High-Throughput Nucleotide Sequencing, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Although several World Health Organization–endorsed targeted next-generation sequencing (tNGS) assays exist for tuberculosis (TB) drug-resistance detection, their target selection and diagnostic accuracy vary widely. In this study, we developed a novel tNGS workflow (the TB Pro assay) and evaluated its performance in identifying Mycobacterium species and predicting drug resistance.
Methods
The TB Pro assay was validated for identifying 10 Mycobacterium tuberculosis complex (MTBC) and 39 nontuberculous mycobacterial (NTM) species, as well as predicting resistance to 4 first-line and 13 second-line anti-TB drugs. The limit of detection (LOD) was determined using 11 reference strains spiked in sputum. The prediction of resistance to anti-tuberculous drugs/drug classes was compared with phenotypic drug susceptibility testing (pDST) and whole-genome sequencing (WGS) using 435 clinical isolates.
Results
The assay demonstrated high sensitivity with a calculated LOD of 3.0 CFU/ml for MTB and 1.4–16.2 CFU/ml for most NTMs, except for Mycobacterium intracellulare with 117.9 CFU/ml. Using pDST as the reference standard, the sensitivity of the TB Pro assay for the detection of resistance ranged from 74.3% (ethambutol) to 94.4% (rifampicin), with specificity values >98% for all drugs. Compared with WGS, the sensitivity of the TB Pro assay was over 98.0% for all drugs except pyrazinamide (66.7%), and the specificity values were all nearly 100.0%. Directly on sputum, the TB Pro assay showed 100% agreement with smear- and culture-positive sputum specimens.
Conclusions
The TB Pro assay represents a sensitive and specific solution for simultaneous mycobacterial identification and comprehensive drug-resistance profiling, performing robustly on both cultured isolates and direct clinical specimens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
- School of Public Health, Peking University, Beijing, China.
- Department of Neurology, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
- Center for Accurate Detection of Tuberculosis, Tianjin Haihe Hospital, Tianjin, China.
- Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands.
- Department of Science and Technology, Chinese Center for Disease Control and Prevention, Beijing, China.
Zitieren
APA
Ou, X., Pei, S., Li, H., Qin, Z., Anthony, R., Wang, J., Song, Z., Xing, R., Zhang, L., Teng, C., Xia, H., Zhou, Y., Song, Y., Zheng, Y., Wang, S., Zhao, B., & Zhao, Y. (2025). A comprehensive evaluation of a novel targeted-sequencing workflow for Mycobacterium species identification and anti-tuberculosis drug-resistance detection. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1584237
Vancouver
Ou X, Pei S, Li H, Qin Z, Anthony R, Wang J, et al. A comprehensive evaluation of a novel targeted-sequencing workflow for Mycobacterium species identification and anti-tuberculosis drug-resistance detection. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1584237
BibTeX
@article{Ou2025,
author = {Ou, Xichao and Pei, Shaojun and Li, Hongru and Qin, Zhonghua and Anthony, Richard and Wang, Jichun and Song, Zexuan and Xing, Ruida and Zhang, Lixia and Teng, Chong and Xia, Hui and Zhou, Yang and Song, Yuanyuan and Zheng, Yang and Wang, Shengfen and Zhao, Bing and Zhao, Yanlin},
title = {A comprehensive evaluation of a novel targeted-sequencing workflow for Mycobacterium species identification and anti-tuberculosis drug-resistance detection},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
volume = {15},
doi = {10.3389/fcimb.2025.1584237}
}
EUVIMED